Kyogoku unyu shoji
9073
BlueMeme
4069
Estore
4304
Visumo
303A
D. Western Therapeutics Institute
4576
(FY)Jul 31, 2024 | (FY)Jul 31, 2023 | (FY)Jul 31, 2022 | (FY)Jul 31, 2021 | (FY)Jul 31, 2020 | (FY)Jul 31, 2019 | (FY)Jul 31, 2018 | (FY)Jul 31, 2017 | (FY)Jul 31, 2016 | (FY)Jul 31, 2015 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating cash flow (Indirect Method) | ||||||||||
Cash from operating activities | -30.66%631M | 23.64%910M | -37.09%736M | 24.60%1.17B | 139.69%939M | -29.40%391.76M | -16.92%554.92M | 39.24%667.91M | 19.09%479.68M | -26.82%402.77M |
Net profit before non-cash adjustment | -40.23%566M | 15.91%947M | -17.64%817M | 76.83%992M | 48.69%561M | -19.85%377.29M | -25.84%470.74M | 14.06%634.74M | 51.41%556.51M | -10.83%367.55M |
Total adjustment of non-cash items | -79.05%22M | 23.53%105M | -27.35%85M | -37.10%117M | 451.65%186M | 21.60%33.72M | 139.35%27.73M | -160.11%-70.47M | 149.40%117.23M | -55.21%47.01M |
-Depreciation and amortization | 9.46%162M | 25.42%148M | 8.26%118M | -6.03%109M | 31.05%116M | 27.56%88.52M | -21.18%69.39M | -13.40%88.03M | -25.28%101.65M | -0.23%136.05M |
-Reversal of impairment losses recognized in profit and loss | ---- | ---- | ---- | ---- | --7M | ---- | ---- | ---- | ---- | --85.16M |
-Assets reserve and write-off | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -70.68%5.56M | 139.68%18.95M |
-Disposal profit | -50.00%-3M | -150.00%-2M | -33.33%4M | 500.00%6M | 115.08%1M | 59.91%-6.63M | 62.99%-16.54M | -360.06%-44.68M | 129.93%17.18M | -75.82%-57.41M |
-Net exchange gains and losses | 33.33%-10M | -50.00%-15M | -433.33%-10M | 50.00%3M | 378.55%2M | -144.02%-718K | -60.18%1.63M | 409.45%4.1M | 212.29%804K | -278.84%-716K |
-Pension and employee benefit expenses | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -12.35%6.9M | -79.71%7.87M |
-Other non-cash items | -388.46%-127M | 3.70%-26M | -2,600.00%-27M | -101.67%-1M | 226.45%60M | -77.33%-47.45M | 77.31%-26.76M | -693.43%-117.92M | 89.60%-14.86M | -1,475.29%-142.89M |
Changes in working capital | 131.91%45M | 14.02%-141M | -373.33%-164M | -68.42%60M | 1,087.22%190M | -134.09%-19.25M | -45.54%56.45M | 153.41%103.65M | -1,546.57%-194.07M | -135.44%-11.79M |
-Change in receivables | 25.35%89M | 208.70%71M | 117.56%23M | 30.69%-131M | -256.35%-189M | -293.70%-53.04M | -73.70%27.38M | 277.52%104.12M | 47.00%-58.65M | -255.99%-110.66M |
-Change in inventory | -38.32%-148M | -94.55%-107M | -150.00%-55M | -23.61%110M | 261.99%144M | -2,151.63%-88.9M | -81.61%4.33M | 150.07%23.56M | -634.72%-47.05M | 131.53%8.8M |
-Change in payables | 200.00%115M | 4.96%-115M | -265.75%-121M | -68.12%73M | 83.60%229M | 439.87%124.73M | 270.04%23.1M | 84.62%-13.59M | -198.10%-88.37M | 1,021.09%90.07M |
-Provision for loans, leases and other losses | -210.00%-11M | 190.91%10M | -237.50%-11M | 33.33%8M | 394.41%6M | -224.95%-2.04M | 115.62%1.63M | ---10.44M | ---- | ---- |
Dividends paid (cash flow from operating activities) | ||||||||||
Dividends received (cash flow from operating activities) | ||||||||||
Interest paid (cash flow from operating activities) | 0.00%-2M | -100.00%-2M | 50.00%-1M | 33.33%-2M | -81.16%-3M | -118.18%-1.66M | -26.92%-759K | 20.69%-598K | 36.21%-754K | -14,675.00%-1.18M |
Interest received (cash flow from operating activities) | 0.00%2M | 0.00%2M | 0.00%2M | 0.00%2M | -27.03%2M | 44.49%2.74M | -26.19%1.9M | -26.38%2.57M | -35.04%3.49M | -29.76%5.37M |
Tax refund paid | -33.78%-301M | 40.48%-225M | -65.07%-378M | -124.51%-229M | -88.53%-102M | 57.41%-54.1M | 48.60%-127.02M | -25.38%-247.12M | -27.33%-197.09M | 30.22%-154.78M |
Other operating cash inflow (outflow) | -105.26%-1M | -9.52%19M | -8.70%21M | 109.09%23M | 266.79%11M | 3M | 0 | -23.58%95.51M | 12,497,700.00%124.98M | -200.00%-1K |
Operating cash flow | -53.27%329M | 85.26%704M | -60.58%380M | 13.81%964M | 147.85%847M | -20.35%341.74M | -17.22%429.04M | 26.32%518.28M | 62.70%410.3M | -25.00%252.18M |
Investing cash flow | ||||||||||
Net PPE purchase and sale | -173.03%-65M | 171.20%89M | -247.22%-125M | 97.18%-36M | -1,419.29%-1.28B | 83.28%-84.12M | -1,478.16%-503.23M | -252.50%-31.89M | 99.26%-9.05M | -73,995.12%-1.22B |
Net intangibles purchase and sale | 17.39%-19M | 34.29%-23M | -52.17%-35M | -64.29%-23M | 32.87%-14M | -13.91%-20.85M | -12.28%-18.31M | 7.63%-16.31M | 36.42%-17.65M | -155.63%-27.76M |
Net business purchase and sale | 65.13%-106M | ---304M | --0 | ---- | 90.87%-21M | ---229.96M | ---- | ---- | ---- | ---- |
Net investment product transactions | -77.05%56M | 8,033.33%244M | -81.25%3M | 60.00%16M | -90.59%10M | 353.86%106.28M | -187.49%-41.87M | -86.24%47.85M | 296.05%347.86M | -17.08%87.83M |
Net changes in other investments | 44.44%-5M | 93.53%-9M | -184.76%-139M | -1.20%164M | 80,093.24%166M | -5.05%207K | -87.25%218K | 1,010.39%1.71M | -99.88%154K | 7,991.42%125.16M |
Investing cash flow | -4,533.33%-139M | 98.99%-3M | -344.63%-296M | 110.64%121M | -397.71%-1.14B | 59.44%-228.45M | -41,268.42%-563.18M | -99.57%1.37M | 131.20%321.32M | -1,221.45%-1.03B |
Financing cash flow | ||||||||||
Net issuance payments of debt | 277.50%355M | -2.56%-200M | -8.94%-195M | -124.72%-179M | 401.45%724M | -165.98%-240.17M | 436.02%364M | -18.18%-108.33M | -128.87%-91.66M | 346.39%317.55M |
Net common stock issuance | ---- | ---- | ---- | ---- | ---- | ---1K | ---- | ---67K | ---- | ---- |
Cash dividends paid | 0.00%-221M | 8.68%-221M | -43.20%-242M | -101.19%-169M | 26.80%-84M | 20.59%-114.75M | 24.45%-144.5M | -66.67%-191.25M | -8.00%-114.75M | -8.70%-106.25M |
Net other fund-raising expenses | 0.00%-1M | 0.00%-1M | 0.00%-1M | 50.00%-1M | -3,433.33%-2M | 6,100.00%60K | 0.00%-1K | ---1K | ---- | 0.00%-1K |
Financing cash flow | 131.52%133M | 3.65%-422M | -25.50%-438M | -154.70%-349M | 279.79%638M | -261.66%-354.86M | 173.26%219.51M | -45.17%-299.64M | -197.69%-206.41M | 193.24%211.3M |
Net cash flow | ||||||||||
Beginning cash position | 12.24%2.6B | -12.59%2.31B | 37.45%2.65B | 21.68%1.93B | -13.03%1.58B | 4.91%1.82B | 14.15%1.73B | 52.73%1.52B | -36.26%994.58M | 14.84%1.56B |
Current changes in cash | 15.77%323M | 178.81%279M | -148.10%-354M | 111.49%736M | 244.06%348M | -382.99%-241.56M | -61.20%85.36M | -58.11%220M | 192.72%525.21M | -381.22%-566.46M |
Effect of exchange rate changes | 333.33%13M | -85.71%3M | 240.00%21M | -275.00%-15M | -185.12%-4M | 1,601.28%4.7M | 93.89%-313K | -537.19%-5.12M | -212.29%-804K | 278.84%716K |
Cash adjustments other than cash changes | ---- | --1M | ---- | ---- | -99,900.00%-1M | ---1K | ---- | ---- | ---- | 0.00%1K |
End cash Position | 12.94%2.93B | 12.24%2.6B | -12.59%2.31B | 37.45%2.65B | 21.68%1.93B | -13.02%1.58B | 4.91%1.82B | 14.15%1.73B | 52.73%1.52B | -36.26%994.58M |
Free cash flow | -61.95%242M | 189.09%636M | -75.69%220M | 303.37%905M | -289.23%-445M | 354.23%235.16M | -119.68%-92.5M | 30.91%470.06M | 136.18%359.08M | -406.61%-992.56M |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |